Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-090-9 | CAS number: 91-68-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- Prediction is done using QSAR Toolbox version 3.1
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Route of administration:
- oral: gavage
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 90 days
- Dose descriptor:
- NOAEL
- Effect level:
- 419 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: Change in body weight
- Critical effects observed:
- not specified
- Conclusions:
- The NOAEL value of 3 diethylaminop phenol in Sprague-Dawley rat in 90 days study was observed at dose concentration of 419 mg/kg bw/day nominal
- Executive summary:
The NOAEL for 3-diethylaminophenol is estimated to be 419mg/kg bw/dayfor rat in90 daysusing the toolbox version 3.2. The data is estimated to be based on the data summarized below
CAS no.
End point
Value
Species
Doses
Duration
Effects
Remarks
108-39-4
NOAEL
824 mg/kg /day
Rattus Norvegicus
100 to 1000mg/kg/day
28 days
no treatment related effect observed on enzymes
108-68-9
NOAEL
30 mg/kg /day
Rat
0, 30, 100, 300mg/kg/day
28 days
No adverse effect observed
108-95-2
NOAEL
153mg/kg /day
Rat
0, 2500,5000 ppm
1.97 yrs
multiple effects not observed
108-46-3
NOAEL
494 mg/kg /day
Mus musculus
28 to 420 mg/kg/day
13 weeks
No change in organ weight
108-73-6
NOAEL
976mg/kg /day
Rat
30 to 1000 mg/kg/day
28 days
Change in body weight
All the values when equalized to 90 days duration by using conversion factor of 3 and the Species are also converted by using conversion factor , the values are summarized as follows
CAS no.
End point
Value
Species
Duration
108-39-4
NOAEL
274.66 mg/kg/day
Rat
90 days
108-68-9
NOAEL
10 mg/kg /day
Rat
90 days
108-95-2
NOAEL
306 mg/kg /day
Rat
90 days
108-46-3
NOAEL
864.5 mg/kg /day
Rat
90 days
108-73-6
NOAEL
325.33 mg/kg /day
Rat
90 days
Thus the calculated NOEL of analogues for 90 days for the species rat is within the range of 10 – 864.5 mg/kg bw /day. Thus the predicted NOEL value is (calculated to be)356.098mg/kg bw/d with 90 days for rat (harmonized using assessment factors) falls within the domain using Log Kow as the descriptor and justified to be used as NOEL for further DNEL calculation for the purpose of risk assessment. Also it does not impact the classification of the substance thus the predicted value considered to be acceptable.
Justified to be used as NOEL for the purpose of weight of evidence
Reference
The
prediction was based on dataset comprised from the following
descriptors: LOEL, LOEL, NOEL, NOEL calculated, study LOEL, studyNOEL"Estimation
method: Takes average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
(((("a"
or "b" or "c" or "d" or "e") and("f"
and(not
"g")) ) and(("h"
or "i" or "j" or "k" or "l") and("m"
and(not
"n")) ) and((("o"
or "p" or "q" or "r" or "s") and("t"
and(not
"u")) ) or(("v"
or "w" or "x" or "y" or "z") and("aa"
and(not
"ab")) ) ) ) and("ac"
and "ad") )
Domain
logical expression index: "a"
Referential
boundary:The
target chemical should be classified as Phenols (Acute toxicity) by
US-EPA New Chemical Categories ONLY
Domain
logical expression index: "b"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Aryl AND
Phenol by Organic functional groups
Domain
logical expression index: "c"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Overlapping
groups AND Phenol by Organic functional groups (nested)
Domain
logical expression index: "d"
Referential
boundary:The
target chemical should be classified as Alcohol, olefinic attach [-OH]
AND Aliphatic Carbon [CH] AND Aliphatic Carbon [-CH2-] AND Aliphatic
Carbon [-CH3] AND Aliphatic Nitrogen, one aromatic attach [-N] AND
Amino, aliphatic attach [-N<] AND Aromatic Carbon [C] AND Hydroxy,
aromatic attach [-OH] AND Olefinic carbon [=CH- or =C<] AND Oxygen, one
aromatic attach [-O-] by Organic functional groups (US EPA)
Domain
logical expression index: "e"
Referential
boundary:The
target chemical should be classified as Amine AND Aromatic compound AND
Hydroxy compound AND Phenol AND Tertiary amine AND Tertiary mixed amine
by Organic functional groups, Norbert Haider (checkmol)
Domain
logical expression index: "f"
Referential
boundary:The
target chemical should be classified as Weak binder, OH group by
Estrogen Receptor Binding
Domain
logical expression index: "g"
Referential
boundary:The
target chemical should be classified as Moderate binder, NH2 group OR
Moderate binder, OH grooup OR Non binder, impaired OH or NH2 group OR
Non binder, MW>500 OR Non binder, without OH or NH2 group OR Strong
binder, NH2 group OR Strong binder, OH group OR Weak binder, NH2 group
OR Very strong binder, OH group by Estrogen Receptor Binding
Domain
logical expression index: "h"
Referential
boundary:The
target chemical should be classified as Phenols (Acute toxicity) by
US-EPA New Chemical Categories ONLY
Domain
logical expression index: "i"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Aryl AND
Phenol by Organic functional groups
Domain
logical expression index: "j"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Overlapping
groups AND Phenol by Organic functional groups (nested)
Domain
logical expression index: "k"
Referential
boundary:The
target chemical should be classified as Alcohol, olefinic attach [-OH]
AND Aliphatic Carbon [CH] AND Aliphatic Carbon [-CH2-] AND Aliphatic
Carbon [-CH3] AND Aliphatic Nitrogen, one aromatic attach [-N] AND
Amino, aliphatic attach [-N<] AND Aromatic Carbon [C] AND Hydroxy,
aromatic attach [-OH] AND Olefinic carbon [=CH- or =C<] AND Oxygen, one
aromatic attach [-O-] by Organic functional groups (US EPA)
Domain
logical expression index: "l"
Referential
boundary:The
target chemical should be classified as Amine AND Aromatic compound AND
Hydroxy compound AND Phenol AND Tertiary amine AND Tertiary mixed amine
by Organic functional groups, Norbert Haider (checkmol)
Domain
logical expression index: "m"
Referential
boundary:The
target chemical should be classified as No alert found by Protein
binding by OASIS v1.1
Domain
logical expression index: "n"
Referential
boundary:The
target chemical should be classified as Acylation OR Acylation >> Acyl
transfer via nucleophilic addition reaction OR Acylation >> Acyl
transfer via nucleophilic addition reaction >> Isocyanates and
isothiocyanates OR Acylation >> Direct acylation involving a leaving
group OR Acylation >> Direct acylation involving a leaving group >>
Carbamates OR Acylation >> Direct acylation involving a leaving group >>
N-acylamides OR Acylation >> Direct acylation involving a leaving group
>> Sulphonyl halides OR Acylation >> Ester aminolysis OR Acylation >>
Ester aminolysis >> Amides OR Acylation >> Ester aminolysis >>
Dithiocarbamates OR Acylation >> Ester aminolysis >> Dithioesters OR
Acylation >> Ester aminolysis or thiolysis OR Acylation >> Ester
aminolysis or thiolysis >> Activated alkyl or aryl esters OR Acylation
>> Ester aminolysis or thiolysis >> Diarylesters OR Acylation >> Ring
opening acylation OR Acylation >> Ring opening acylation >> Active
cyclic agents OR Michael addition OR Michael addition >> Michael
addition on conjugated systems with electron withdrawing group OR
Michael addition >> Michael addition on conjugated systems with electron
withdrawing group >> alpha,beta-carbonyl compounds with polarized double
bonds OR Michael addition >> Michael addition on conjugated systems with
electron withdrawing group >> Cyanoalkenes OR Michael addition >>
Michael addition on conjugated systems with electron withdrawing group
>> Nitroalkenes OR Michael addition >> Michael addition on conjugated
systems with electron withdrawing group >> Vinyl sulfonyl compounds OR
Michael addition >> Michael type addition on vinyl pirydines and
activated ethenylarenes OR Michael addition >> Michael type addition on
vinyl pirydines and activated ethenylarenes >> Activated electrophilic
ethenylarenes OR Michael addition >> Michael type addition on vinyl
pirydines and activated ethenylarenes >> Vinyl pyridines OR Michael
addition >> Quinone type compounds OR Michael addition >> Quinone type
compounds >> Naphtoquinone and naphtoquinone imines OR Michael addition
>> Quinone type compounds >> Quinone (di)imines OR Michael addition >>
Quinone type compounds >> Quinone methides OR Michael addition >>
Quinone type compounds >> Quinones OR Nucleophilic addition OR
Nucleophilic addition >> Addition to Carbon-hetero double/triple bond OR
Nucleophilic addition >> Addition to Carbon-hetero double/triple bond >>
Ketones OR Nucleophilic addition >> Addition to Carbon-hetero
double/triple bond >> Thiocyanates OR Nucleophilic addition >>
Nucleophilic addition at polarized N-functional double bond OR
Nucleophilic addition >> Nucleophilic addition at polarized N-functional
double bond >> C-Nitroso compounds OR Schiff base formation OR Schiff
base formation >> Nucleophilic cycloaddition to diketones OR Schiff base
formation >> Nucleophilic cycloaddition to diketones >> Diketones OR
Schiff base formation >> Pyrazolones and pyrazolidinones derivatives OR
Schiff base formation >> Pyrazolones and pyrazolidinones derivatives >>
Pyrazolones and pyrazolidinones OR Schiff base formation >> Schiff base
formation with carbonyl compounds OR Schiff base formation >> Schiff
base formation with carbonyl compounds >> Aldehydes OR SN1 OR SN1 >>
Nucleophilic substitution (SN1) on alkyl (aryl) mercury cations OR SN1
>> Nucleophilic substitution (SN1) on alkyl (aryl) mercury cations >>
Mercury compounds OR SN2 OR SN2 >> Interchange reaction with sulphur
containing compounds OR SN2 >> Interchange reaction with sulphur
containing compounds >> Thiols and disulfide compounds OR SN2 >>
Nucleophilic substitution at sp3 Carbon atom OR SN2 >> Nucleophilic
substitution at sp3 Carbon atom >> alpha-activated haloalkanes OR SN2 >>
Nucleophilic substitution at sp3 Carbon atom >> alpha-haloalkanes OR SN2
>> Nucleophilic substitution at sp3 Carbon atom >> Phosphonates OR SN2
>> Nucleophilic substitution on benzylic carbon atom OR SN2 >>
Nucleophilic substitution on benzylic carbon atom >> alpha-activated
benzyls OR SN2 >> Nucleophilic substitution on heterocyclic sulfenamides
OR SN2 >> Nucleophilic substitution on heterocyclic sulfenamides >>
Heterocyclic sulfenamides OR SN2 >> Ring opening SN2 reaction OR SN2 >>
Ring opening SN2 reaction >> Epoxides, Aziridines and Sulfuranes OR SNAr
OR SNAr >> Nucleophilic aromatic substitution on activated halogens OR
SNAr >> Nucleophilic aromatic substitution on activated halogens >>
Activated haloarenes by Protein binding by OASIS v1.1
Domain
logical expression index: "o"
Referential
boundary:The
target chemical should be classified as Phenols (Acute toxicity) by
US-EPA New Chemical Categories ONLY
Domain
logical expression index: "p"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Aryl AND
Phenol by Organic functional groups
Domain
logical expression index: "q"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Overlapping
groups AND Phenol by Organic functional groups (nested)
Domain
logical expression index: "r"
Referential
boundary:The
target chemical should be classified as Alcohol, olefinic attach [-OH]
AND Aliphatic Carbon [CH] AND Aliphatic Carbon [-CH2-] AND Aliphatic
Carbon [-CH3] AND Aliphatic Nitrogen, one aromatic attach [-N] AND
Amino, aliphatic attach [-N<] AND Aromatic Carbon [C] AND Hydroxy,
aromatic attach [-OH] AND Olefinic carbon [=CH- or =C<] AND Oxygen, one
aromatic attach [-O-] by Organic functional groups (US EPA)
Domain
logical expression index: "s"
Referential
boundary:The
target chemical should be classified as Amine AND Aromatic compound AND
Hydroxy compound AND Phenol AND Tertiary amine AND Tertiary mixed amine
by Organic functional groups, Norbert Haider (checkmol)
Domain
logical expression index: "t"
Referential
boundary:The
target chemical should be classified as No alert found by DNA binding by
OASIS v.1.1
Domain
logical expression index: "u"
Referential
boundary:The
target chemical should be classified as Acylation OR Acylation >> Direct
acyation involving a leaving group OR Acylation >> Direct acyation
involving a leaving group >> Geminal Polyhaloalkanes OR Elimination (E2)
OR Elimination (E2) >> E2 elimination reaction with epoxide formation OR
Elimination (E2) >> E2 elimination reaction with epoxide formation >>
Haloalcohols OR Michael addition OR Michael addition >> alpha,
beta-unsaturated carabonyl compounds OR Michael addition >> alpha,
beta-unsaturated carabonyl compounds >> Four- and Five-Membered Lactones
OR Michael addition >> Quinone type compounds OR Michael addition >>
Quinone type compounds >> Quinoneimine Derivatives OR Michael addition
>> Quinone type compounds >> Quinones OR Radical OR Radical >>
Generation of reactive oxygen species OR Radical >> Generation of
reactive oxygen species >> Coumarins OR Radical >> Generation of
reactive oxygen species >> Thiols OR Radical >> Radical mechanism by ROS
formation OR Radical >> Radical mechanism by ROS formation >> Geminal
Polyhaloalkanes OR Radical >> Radical mechanism by ROS formation >>
Nitro Compounds OR Radical >> Radical mechanism by ROS formation >>
Nitroso compounds OR Radical >> Radical mechanism by ROS formation >>
Quinones OR Radical >> Radical mechanism by ROS formation >> Specific
Imine and Thione Derivatives OR Radical >> ROS formation after GSH
depletion OR Radical >> ROS formation after GSH depletion >> Aromatic
and Heterocyclic Primary Amines OR Radical >> ROS formation after GSH
depletion >> Haloalcohols OR Radical >> ROS formation after GSH
depletion >> Quinoneimine Derivatives OR Schiff base fomers OR Schiff
base fomers >> Direct acting Schiff base formers OR Schiff base fomers
>> Direct acting Schiff base formers >> Geminal Polyhaloalkanes OR
Schiff base fomers >> Direct acting Schiff base formers >> Specific
Acetate Esters OR Schiff base fomers >> Multi-step Shiff base formation
OR Schiff base fomers >> Multi-step Shiff base formation >> Haloalkanes
Containing Electron-Withdrawing Groups OR SN1 OR SN1 >> Carbenium ion
formation OR SN1 >> Carbenium ion formation >> Nitroso compounds OR SN1
>> Carbenium ion formation >> Polycyclic Aromatic Hydrocarbons OR SN1 >>
Carbenium ion formation >> Specific Acetate Esters OR SN1 >>
Glutathione-induced nitrenium ion formation OR SN1 >>
Glutathione-induced nitrenium ion formation >> Nitroso compounds OR SN1
>> Nitrenium and/or Carbenium ion formation OR SN1 >> Nitrenium and/or
Carbenium ion formation >> Urea Derivatives OR SN1 >> Nitrenium ion
formation OR SN1 >> Nitrenium ion formation >> Aromatic and Heterocyclic
Primary Amines OR SN1 >> Nitrenium ion formation >> N-hydroxylamines OR
SN1 >> Nitrenium ion formation >> Nitro Compounds OR SN1 >>
Non-enzymatic nitroso radical and/or nirtosonium cation formation OR SN1
>> Non-enzymatic nitroso radical and/or nirtosonium cation formation >>
Nitroso compounds OR SN1 >> Non-enzymatic nitroso radical and/or
nirtosonium cation formation >> Urea Derivatives OR SN2 OR SN2 >>
Acylating agents OR SN2 >> Acylating agents >> Specific Acetate Esters
OR SN2 >> Carbenium Ion Formation OR SN2 >> Carbenium Ion Formation >>
Diazoalkanes OR SN2 >> Diazonium ion formation OR SN2 >> Diazonium ion
formation >> Specific Imine and Thione Derivatives OR SN2 >> Direct
Acting Epoxides and Related OR SN2 >> Direct Acting Epoxides and Related
>> Epoxides, Aziridines OR SN2 >> Epoxidation of Aliphatic Alkenes OR
SN2 >> Epoxidation of Aliphatic Alkenes >> Polarized Haloalkene
Derivatives OR SN2 >> Nucleophilic substitution at sp3 Carbon atom OR
SN2 >> Nucleophilic substitution at sp3 Carbon atom >> Geminal
Polyhaloalkanes OR SN2 >> Nucleophilic substitution at sp3 Carbon atom
>> Haloalkanes Containing Electron-Withdrawing Groups OR SN2 >>
Nucleophilic substitution at sp3 Carbon atom >> Haloalkanes Containing
Heteroatom OR SN2 >> P450-mediated epoxidation OR SN2 >> P450-mediated
epoxidation >> Coumarins OR SN2 >> P450-mediated epoxidation >>
Polarized Haloalkene Derivatives OR SN2 >> P450-mediated epoxidation >>
Polycyclic Aromatic Hydrocarbons OR SN2 >> Ring opening SN2 reaction OR
SN2 >> Ring opening SN2 reaction >> Four- and Five-Membered Lactones OR
SN2 >> SN2 at sp3 and activated sp2 carbon atom OR SN2 >> SN2 at sp3 and
activated sp2 carbon atom >> Polarized Haloalkene Derivatives OR SN2 >>
SN2 at sp3-carbon atom OR SN2 >> SN2 at sp3-carbon atom >>
Alkylphosphates, Alkylthiophosphates and Alkylphosphonates OR SN2 >> SN2
at sp3-carbon atom >> Specific Acetate Esters OR SN2 >> SN2 at
sp3-carbon atom >> Sulfonates and Sulfates OR SN2 >> SN2 at sulfur atom
OR SN2 >> SN2 at sulfur atom >> Sulfonyl Halides by DNA binding by OASIS
v.1.1
Domain
logical expression index: "v"
Referential
boundary:The
target chemical should be classified as Phenols (Acute toxicity) by
US-EPA New Chemical Categories ONLY
Domain
logical expression index: "w"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Aryl AND
Phenol by Organic functional groups
Domain
logical expression index: "x"
Referential
boundary:The
target chemical should be classified as Aromatic amine AND Overlapping
groups AND Phenol by Organic functional groups (nested)
Domain
logical expression index: "y"
Referential
boundary:The
target chemical should be classified as Alcohol, olefinic attach [-OH]
AND Aliphatic Carbon [CH] AND Aliphatic Carbon [-CH2-] AND Aliphatic
Carbon [-CH3] AND Aliphatic Nitrogen, one aromatic attach [-N] AND
Amino, aliphatic attach [-N<] AND Aromatic Carbon [C] AND Hydroxy,
aromatic attach [-OH] AND Olefinic carbon [=CH- or =C<] AND Oxygen, one
aromatic attach [-O-] by Organic functional groups (US EPA)
Domain
logical expression index: "z"
Referential
boundary:The
target chemical should be classified as Amine AND Aromatic compound AND
Hydroxy compound AND Phenol AND Tertiary amine AND Tertiary mixed amine
by Organic functional groups, Norbert Haider (checkmol)
Domain
logical expression index: "aa"
Referential
boundary:The
target chemical should be classified as SN1 AND SN1 >> Nitrenium Ion
formation AND SN1 >> Nitrenium Ion formation >> Tertiary aromatic amine
by DNA binding by OECD
Domain
logical expression index: "ab"
Referential
boundary:The
target chemical should be classified as Acylation OR Acylation >>
Isocyanates and Isothiocyanates OR Acylation >> Isocyanates and
Isothiocyanates >> Isothiocyanates OR Acylation >> P450 Mediated
Activation to Isocyanates or Isothiocyanates OR Acylation >> P450
Mediated Activation to Isocyanates or Isothiocyanates >> Formamides OR
Michael addition OR Michael addition >> P450 Mediated Activation of
Heterocyclic Ring Systems OR Michael addition >> P450 Mediated
Activation of Heterocyclic Ring Systems >> Furans OR Michael addition >>
P450 Mediated Activation of Heterocyclic Ring Systems >>
Thiophenes-Michael addition OR Michael addition >> P450 Mediated
Activation to Quinones and Quinone-type Chemicals OR Michael addition >>
P450 Mediated Activation to Quinones and Quinone-type Chemicals >>
5-alkoxyindoles OR Michael addition >> P450 Mediated Activation to
Quinones and Quinone-type Chemicals >> Alkyl phenols OR Michael addition
>> P450 Mediated Activation to Quinones and Quinone-type Chemicals >>
Arenes OR Michael addition >> P450 Mediated Activation to Quinones and
Quinone-type Chemicals >> Hydroquinones OR Michael addition >> P450
Mediated Activation to Quinones and Quinone-type Chemicals >>
Methylenedioxyphenyl OR Michael addition >> P450 Mediated Activation to
Quinones and Quinone-type Chemicals >> Polycyclic (PAHs) and
heterocyclic (HACs) aromatic hydrocarbons-Michael addition OR Michael
addition >> Polarised Alkenes-Michael addition OR Michael addition >>
Polarised Alkenes-Michael addition >> Alpha, beta- unsaturated amides OR
Michael addition >> Polarised Alkenes-Michael addition >> Alpha, beta-
unsaturated ketones OR Michael addition >> Quinones and Quinone-type
Chemicals OR Michael addition >> Quinones and Quinone-type Chemicals >>
Quinones OR No alert found OR Schiff base formers OR Schiff base formers
>> Chemicals Activated by P450 to Glyoxal OR Schiff base formers >>
Chemicals Activated by P450 to Glyoxal >> Ethanolamines (including
morpholine) OR Schiff base formers >> Chemicals Activated by P450 to
Mono-aldehydes OR Schiff base formers >> Chemicals Activated by P450 to
Mono-aldehydes >> Thiazoles OR Schiff base formers >> Direct Acting
Schiff Base Formers OR Schiff base formers >> Direct Acting Schiff Base
Formers >> Alpha-beta-dicarbonyl OR SN1 >> Carbenium Ion Formation OR
SN1 >> Carbenium Ion Formation >> Allyl benzenes OR SN1 >> Carbenium Ion
Formation >> Diazoalkanes OR SN1 >> Carbenium Ion Formation >>
Polycyclic (PAHs) and heterocyclic (HACs) aromatic hydrocarbons-SN1 OR
SN1 >> Iminium Ion Formation OR SN1 >> Iminium Ion Formation >>
Aliphatic tertiary amines OR SN1 >> Nitrenium Ion formation >> Aromatic
azo OR SN1 >> Nitrenium Ion formation >> Aromatic N-hydroxylamines OR
SN1 >> Nitrenium Ion formation >> Aromatic nitro OR SN1 >> Nitrenium Ion
formation >> Aromatic nitroso OR SN1 >> Nitrenium Ion formation >>
Aromatic phenylureas OR SN1 >> Nitrenium Ion formation >> Primary
(unsaturated) heterocyclic amine OR SN1 >> Nitrenium Ion formation >>
Primary aromatic amine OR SN1 >> Nitrenium Ion formation >> Secondary
aromatic amine OR SN1 >> Nitrenium Ion formation >> Unsaturated
heterocyclic azo OR SN1 >> Nitrenium Ion formation >> Unsaturated
heterocyclic nitro OR SN2 OR SN2 >> Direct Acting Epoxides and related
OR SN2 >> Direct Acting Epoxides and related >> Aziridines OR SN2 >>
Direct Acting Epoxides and related >> Epoxides OR SN2 >> Epoxidation of
Aliphatic Alkenes OR SN2 >> Epoxidation of Aliphatic Alkenes >> Phenoxy
polarised alkenes OR SN2 >> P450 Mediated Epoxidation OR SN2 >> P450
Mediated Epoxidation >> Coumarins OR SN2 >> P450 Mediated Epoxidation >>
Thiophenes-SN2 OR SN2 >> Ring opening SN2 Reaction OR SN2 >> Ring
opening SN2 Reaction >> Lactones OR SN2 >> SN2 at an sp3 Carbon atom OR
SN2 >> SN2 at an sp3 Carbon atom >> Aliphatic halides OR SN2 >> SN2 at
an sp3 Carbon atom >> Phosphonic esters by DNA binding by OECD
Domain
logical expression index: "ac"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= 1.03
Domain
logical expression index: "ad"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 3.52
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 419 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- K2 data from QSAR model considered reliable by OECD
Repeated dose toxicity: inhalation - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
- Qualifier:
- according to guideline
- Guideline:
- other: estimated data
- Principles of method if other than guideline:
- Prediction is done using QSAR Toolbox version 2.3.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- not specified
- Route of administration:
- inhalation
- Type of inhalation exposure:
- not specified
- Vehicle:
- not specified
- Analytical verification of doses or concentrations:
- not specified
- Dose descriptor:
- LOEL
- Effect level:
- 26.912 other: mg/kg/day
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: lowest adverse effect level
- Critical effects observed:
- not specified
- Conclusions:
- Repeated dose toxicity LOEL (Lowest observed effect level) of 3-diethylaminophenol to rat by the inhalation route was estimated at a dose concentration of 26.91227 mg/kg/day.
- Executive summary:
Repeated dose toxicity LOEL (Lowest observed effect level) of 3-diethylaminophenol to rat by the inhalation route was estimated at a dose concentration of 26.91227 mg/kg/day. This indicates that 3-diethylaminophenol shall not exhibit toxic effect to rat by the inhalation route below the above mention dose.
Reference
The
prediction was based on dataset comprised from the following
descriptors: "study LOEL"
Estimation method: Taking average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
(("a"
and ("b"
and (
not "c")
)
)
and ("d"
and "e" )
)
Domain
logical expression index: "a"
Similarity
boundary:Target:
c1(O)cc(N(CC)CC)ccc1
Threshold=50%,
Dice(Atom pairs;Topologic torsions;Atom centered fragments;Path;Cycles)
Domain
logical expression index: "b"
Referential
boundary: The
target chemical should be classified as Alcohol, olefinic attach [-OH]
AND Aliphatic Carbon [CH] AND Aliphatic Carbon [-CH2-] AND Aliphatic
Carbon [-CH3] AND Aliphatic Nitrogen, one aromatic attach [-N] AND
Amino, aliphatic attach [-N<] AND Aromatic Carbon [C] AND Hydroxy,
aromatic attach [-OH] AND Olefinic carbon [=CH- or =C<] AND Oxygen, one
aromatic attach [-O-] by Organic functional groups (US EPA)
Domain
logical expression index: "c"
Referential
boundary: The
target chemical should be classified as Acetylenic Carbon [#C] OR
Aliphatic Nitrogen, two aromatic attach [-N-] OR Chlorine, aromatic
attach [-Cl] OR Chlorine, olefinic attach [-Cl] OR Isocyanate, aromatic
attach [-N=C=O] OR Miscellaneous sulfide (=S) or oxide (=O) OR Nitro,
aromatic attach [-NO2] OR Nitrogen, two or tree olefinic attach [>N-] by
Organic functional groups (US EPA)
Domain
logical expression index: "d"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= 0.154
Domain
logical expression index: "e"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 2.61
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- 26.912
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- K2 data from QSAR model considered reliable by OECD
Repeated dose toxicity: dermal - systemic effects
Link to relevant study records
- Endpoint:
- chronic toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- The potential carcinogenicity and toxicity of several commonly used cutaneous agents of which one is resocersinol were studied in female Swiss mice by administering repeated applications of the chemical on the skin for the life-span of the animals
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Eppley colony
- Age at study initiation: Seven-week-old
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: plastic cages with commercial bedding
- Diet (e.g. ad libitum):commercial diet Wayne, Allied Mills, ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
IN-LIFE DATES: From: To: - Type of coverage:
- open
- Vehicle:
- acetone
- Details on exposure:
- TEST SITE
- Area of exposure: dorsal skin between the flanks
- % coverage: l-inch square area
- Type of wrap if used: no data
- Time intervals for shavings or clipplings: shaved regularly.
REMOVAL OF TEST SUBSTANCE
- Washing (if done):no data
- Time after start of exposure:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.02 ml
- Concentration (if solution): 5, 25,50 %
- Constant volume or concentration used: no data
- For solids, paste formed: no data - Duration of treatment / exposure:
- life time
- Frequency of treatment:
- twice a week
- Remarks:
- Doses / Concentrations:
0,5,25,50% (8333.33, 41666.6, 83333.3 mg/kg bw/day)
Basis:
nominal per unit area - No. of animals per sex per dose:
- 50/dose group
- Control animals:
- yes, concurrent vehicle
- Positive control:
- 7,12-dimethylbenzanthracene
- Sacrifice and pathology:
- The animals were checked weekly, and all lesions, as well as tumors, were recorded. Animals were allowed to die spontaneously or were killed when moribund. Complete autopsies were performed on all animals. The skin from all animals, all grossly observed tumors and other lesions in the lungs, livers, kidneys, etc., from treated as well as control groups were studied histologically. Formalin-fixed paraffin-embedded specimens were cut and stained with hematoxylin-eosin and other stains when needed.
- Statistics:
- The statistical significance of the results was evaluated using the methods presented by Armitage
- Clinical signs:
- no effects observed
- Dermal irritation:
- effects observed, treatment-related
- Mortality:
- no mortality observed
- Body weight and weight changes:
- not examined
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Details on results:
- Animals treated with resorcinol showed skin lesions with ulceration, inflammation and hyperplasia. Two skin tumors were seen, 1 on the back and 1 on the ear as well as 1 subcutaneous fibrosarcoma.
- Dose descriptor:
- LOAEL
- Effect level:
- 8 333.33 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: skin lesions with ulceration, inflammation and hyperplasia was observed
- Critical effects observed:
- not specified
- Conclusions:
- The LOAEL of resorcinol in female swiss mice in a life time study was observed at dose concentration of 8333.33 mg/kg bw/day
- Executive summary:
50 female swiss mice were applied resorcinol at dose concentration of 0,5,25,50% (8333.33, 41666.6, 83333.3 mg/kg bw/day) (0.02 ml) were dropped on the dorsal skin between the flanks twice a week on a l-inch square area which was shaved regularly. The animals
were checked weekly, and all lesions, as well as tumors, were recorded. Animals treated with resorcinol showed skin lesions with ulceration, inflammation and hyperplasia. Two skin tumors were seen, 1 on the back and 1 on the ear as well as 1 subcutaneous fibrosarcoma. Hence the LOAEL was considered to be 8333.33 mg/kg bw/day.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LOAEL
- 8 333.33 mg/kg bw/day
- Study duration:
- chronic
- Species:
- mouse
- Quality of whole database:
- K2 level data from relaible journal toxicology and applied pharmocology
Additional information
Repeated dose toxicity : Oral :
Based on the various studies available with Klimish rating 2 and 4 for the target as well as read across substances for CAS NO 91-68-9, also from category based on organic functional group along with similar mechanistic approach and having structural similarities defined by QSAR toolbox. The results for target as well as analogues are summarized as follows
Sr. No |
End point |
Value |
Species |
Route |
Effects |
Remarks |
1 |
NOAEL |
419 mg/ kg bw/day |
rat |
Oral |
Change in body weight |
Predicted data for target chemical
|
2 |
NOAEL (female)
NOAEL (male) |
27.5 mg/Kg bw /d
110 mg/Kg bw /d
|
Rat |
Oral |
hyperexcitability at doses at and greater than 55 mg/kg bw along with tachypnea at 110 and 450 mg/kg bw. Decreased absoluteand relative thymus weights were observed at 450 mg/kg bw. hyperexcitability and tachypnea at 225 mg/kg bw. |
Data from study report for CAS NO 108-46-3 |
3 |
NOAEL (male)
NOAEL (female)
|
75 mg/kg bw/d
150 mg/kg bw/d
|
Rat
|
Oral
|
prostration and tremors at 150 mg/kg bw. 80% mortality at 600 mg/kg bw, 20% mortality at 300 mg/kg bw and absence of any other significant differences when compared to controls.
prostration and tremors at 300 mg/kg bw. Complete mortality at 600 mg/kg bw; no other significant findings. |
Data from study report for CAS NO 108-46-3 |
4 |
NOAEL (male)
NOAEL (female)
|
65 mg/kg bw/d
32 mg/kg bw/d
|
Rat
|
Oral
|
increased absolute liver weights at 130 and 260 mg/kg/bw. Tremors were observed at 520 mg/kg bw. Absolute and relative adrenal gland weights were significantly increased in all surviving male doses groups.
increased absolute and relative liver weights at 65 mg/kg/bw. Tremors were observed at 520 mg/kg bw. |
Data from study report for CAS NO 108-46-3 |
5 |
NOAEL (male)
|
225 mg/kg bw/d |
Rat |
Oral |
dyspnea, prostration, and tremors occuring at the highest dose of 420 mg/kg bw. Mortality at 420 mg/kg bw. |
Data from study report for CAS NO 108-46-3 |
Based on the studies summarized in the above table it can be observed that NOAEL values was found to be in the range of 27.5 - 419 mg/Kg bw/ d. The effects observed on these doses was listed as follows
· Change in body weight
· hyperexcitability at doses at and greater than 55 mg/kg bw along with tachypnea at 110 and 450 mg/kg bw. Decreased absoluteand relative thymus weights were observed at 450 mg/kg bw.
· hyperexcitability and tachypnea at 225 mg/kg bw.
· prostration and tremors at 150 mg/kg bw. 80% mortality at 600 mg/kg bw, 20% mortality at 300 mg/kg bw and absence of any other significant differences when compared to controls.
· prostration and tremors at 300 mg/kg bw. Complete mortality at 600 mg/kg bw; no other significant findings.
· increased absolute liver weights at 130 and 260 mg/kg/bw. Tremors were observed at 520 mg/kg bw. Absolute and relative adrenal gland weights were significantly increased in all surviving male doses groups.
· increased absolute and relative liver weights at 65 mg/kg/bw. Tremors were observed at 520 mg/kg bw.
· dyspnea, prostration, and tremors occuring at the highest dose of 420 mg/kg bw. Mortality at 420 mg/kg bw.
Thus based on above values it can be concluded that substance CAS NO 91-68-9 is expected to show the similar toxicological effect based on the effects observed on the other category members. Since no effective dose value (NOAEL) is 27.5 mg/Kg bw/d thus based on this value it can be concluded that substance CAS NO 91-68-9 is considered to be not toxic to repeated dose via oral route for the above mentioned dose. Also there are no known evidence of adverse effect to Human of CAS NO 91-68-9 as well as mechanistic trigger does not indicates any concern of CAS NO 91-68-9 on toxicity to human.
Repeated dose toxicity : Inhalation :
Based on the various studies available with Klimish rating 2 and 4 for the target as well as read across substances for CAS NO 91-68-9, also from category based on organic functional group along with similar mechanistic approach and having structural similarities defined by QSAR toolbox. The results for target as well as analogues are summarized as follows
Sr. No |
End point |
Value |
Species |
Route |
Effects |
Remarks |
1 |
LOEL |
26.91227 mg/kg/day |
rat |
Inhalation |
- |
Predicted data for target chemical
|
2 |
LOAEL
|
1000 mg/m3
|
Rat |
Inhalation mist |
Systemic effect observed |
Data from study report for CAS NO 108-46-3 |
Based on the studies summarized in the above table it can be observed that LOEL values was found to be in the range of 26.91227mg/kg bw/day - 1000 mg/m3. The effects observed on these doses was listed as follows
· Systemic effect observed
Thus based on above values it can be concluded that substance CAS NO 91-68-9 is expected to show the similar toxicological effect based on the effects observed on the other category members. Since Low effective dose value (LOEL) is 26.91227mg/Kg bw/d thus based on this value it can be concluded that substance CAS NO 91-68-9 is considered to be not toxic to repeated dose via inhalation route below the above mentioned dose. Also there are no known evidence of adverse effect to Human of CAS NO 91-68-9 as well as mechanistic trigger does not indicates any concern of CAS NO 91-68-9 on toxicity to human. Repeated dose toxicity dermal:
50 female swiss mice were applied resorcinol at dose concentration of 0,5,25,50% (8333.33, 41666.6, 83333.3 mg/kg bw/day) (0.02 ml) were dropped on the dorsal skin between the flanks twice a week on a l-inch square area which was shaved regularly. The animals
were checked weekly, and all lesions, as well as tumors, were recorded. Animals treated with resorcinol showed skin lesions with ulceration, inflammation and hyperplasia. Two skin tumors were seen, 1 on the back and 1 on the ear as well as 1 subcutaneous fibrosarcoma. Hence the LOAEL was considered to be 8333.33 mg/kg bw/day.
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
The NOAEL value of 3 diethylaminop phenol in Sprague-Dawley rat in 90 days study was observed at dose concentration of 419 mg/kg bw/day nominal This indicates that 3-diethylaminophenol shall not exhibit toxic effect to rat by the oral route below the above mention dose.
Justification for selection of repeated dose toxicity inhalation - systemic effects endpoint:
Repeated dose toxicity LOEL (Lowest observed effect level) of 3-diethylaminophenol to rat by the inhalation route was estimated at a dose concentration of 26.91227 mg/kg/day. This indicates that 3-diethylaminophenol shall not exhibit toxic effect to rat by the inhalation route below the above mention dose.
Justification for selection of repeated dose toxicity dermal - systemic effects endpoint:
50 female swiss mice were applied resorcinol at dose concentration of 0,5,25,50% (8333.33, 41666.6, 83333.3 mg/kg bw/day) (0.02 ml) were dropped on the dorsal skin between the flanks twice a week on a l-inch square area which was shaved regularly. The animals were checked weekly, and all lesions, as well as tumors, were recorded. Animals treated with resorcinol showed skin lesions with ulceration, inflammation and hyperplasia. Two skin tumors were seen, 1 on the back and 1 on the ear as well as 1 subcutaneous fibrosarcoma. Hence the LOAEL was considered to be 8333.33 mg/kg bw/day.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.